BMY
Bristol-Myers Squibb Co
Pharmaceuticals
Bristol-Myers Squibb Co (BMY) Financials
Annual revenue, profit, EPS and free cash flow for BMY, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $48.2B | — | — | $7.1B | $3.46 | $12.8B |
| FY2024 | $48.3B | — | — | $-8.9B | -$4.41 | $13.9B |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.